Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-α gene therapy in esophageal cancer
- 31 August 2005
- Vol. 138 (2) , 261-268
- https://doi.org/10.1016/j.surg.2005.04.011
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinomaLung Cancer, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Tumour necrosis factor α up-regulates protein kinase R (PKR)-activating protein (PACT) and increases phosphorylation of PKR and eukaryotic initiation factor 2-α in articular chondrocytesBiochemical Society Transactions, 2002
- TNFerade Biologic: Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha geneCancer Gene Therapy, 2002
- Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosisOncogene, 2002
- PACT, a Stress-modulated Cellular Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKRJournal of Biological Chemistry, 2000
- A p75 tumor necrosis factor receptor-specific mutant of murine tumor necrosis factor α expressed from an adenovirus vector induces an antitumor response with reduced toxicityCancer Gene Therapy, 1999
- Initiation of Protein Synthesis in Eukaryotic CellsEuropean Journal of Biochemistry, 1996
- Role of the RNA-dependent protein kinase in the regulated expression of genes in transfected cellsPharmacology & Therapeutics, 1992